{
  "DOI": "10.1007/s10689-023-00356-x",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-023-00356-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eInherited cardiovascular diseases cover the inherited cardiovascular disease familial hypercholesterolemia and inherited cardiac diseases, like inherited cardiomyopathies and inherited arrhythmia syndromes. Cascade genetic counseling and testing in inherited cardiovascular diseases have had three decades of academic attention. Inherited cardiovascular diseases affect around 1–2% of the population worldwide and cascade genetic counseling and testing are considered valuable since preventive measures and/or treatments are available. Cascade genetic counseling via a family-mediated approach leads to an uptake of genetic counseling and testing among at-risk relatives of around 40% one year after identification of the causal variant in the proband, with uptake remaining far from complete on the long-term. These findings align with uptake rates among relatives at-risk for other late onset medically actionable hereditary diseases, like hereditary cancer syndromes. Previous interventions to increase uptake have focused on optimizing the process of informing relatives through the proband and on contacting relatives directly. However, despite successful information dissemination to at-risk relatives, these approaches had little or no effect on uptake. The limited research into the barriers that impede at-risk relatives from seeking counseling has revealed knowledge, attitudinal, social and practical barriers but it remains unknown how these factors contribute to the decision-making process for seeking counseling in at-risk relatives. A significant effect on uptake of genetic testing has only been reached in the setting of familial hypercholesterolemia, where active information provision was accompanied by a reduction of health-system-related barriers. We propose that more research is needed on barriers -including health-system-related barriers- and how they hinder counseling and testing in at-risk relatives, so that uptake can be optimized by (adjusted) interventions.\u003c/jats:p\u003e",
  "alternative-id": [
    "356"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "26 October 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "20 December 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "6 January 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-1940-6938",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Grutters",
      "given": "Laura A.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-5799-2344",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Christiaans",
      "given": "Imke",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        1,
        6
      ]
    ],
    "date-time": "2024-01-06T21:15:00Z",
    "timestamp": 1704575700000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        1,
        8
      ]
    ],
    "date-time": "2024-01-08T13:14:31Z",
    "timestamp": 1704719671000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        9
      ]
    ],
    "date-time": "2024-01-09T00:21:01Z",
    "timestamp": 1704759661774
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2024,
        1,
        6
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            1,
            6
          ]
        ],
        "date-time": "2024-01-06T00:00:00Z",
        "timestamp": 1704499200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            1,
            6
          ]
        ],
        "date-time": "2024-01-06T00:00:00Z",
        "timestamp": 1704499200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00356-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-023-00356-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00356-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2024,
        1,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        1,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1080/17431380410032526",
      "author": "IM Van Langen",
      "doi-asserted-by": "publisher",
      "first-page": "116",
      "journal-title": "Ann Med",
      "key": "356_CR1",
      "unstructured": "Van Langen IM, Hofman N, Tan HL, Wilde AAM (2004) Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med 36:116–124. https://doi.org/10.1080/17431380410032526",
      "volume": "36",
      "year": "2004"
    },
    {
      "DOI": "10.1161/CIRCOUTCOMES.110.957365",
      "author": "M Perez",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Circ Cardiovasc Qual Outcomes",
      "key": "356_CR2",
      "unstructured": "Perez M, Kumarasamy N, Owens D, Wang P, Hlatky M (2011) Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome. Circ Cardiovasc Qual Outcomes 4:76–84. https://doi.org/10.1161/CIRCOUTCOMES.110.957365",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1136/heartjnl-2011-300368",
      "doi-asserted-by": "crossref",
      "key": "356_CR3",
      "unstructured": "Ingles J, McGaughran J, Scuffham P, Atherton J, Semsarian C (2012) A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart. ;98:625–30. https://doi.org/0.1136/heartjnl-2011-300368"
    },
    {
      "DOI": "10.1093/eurheartj/ehq067",
      "author": "S Wordsworth",
      "doi-asserted-by": "publisher",
      "first-page": "926",
      "journal-title": "Eur Hear J",
      "key": "356_CR4",
      "unstructured": "Wordsworth S, Leal J, Blair E, Legood R, Thomson K, Seller A et al (2010) DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. Eur Hear J 31:926–935. https://doi.org/10.1093/eurheartj/ehq067",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s12471-023-01776-1",
      "author": "I Wiethoff",
      "doi-asserted-by": "publisher",
      "first-page": "226",
      "journal-title": "Neth Hear J",
      "key": "356_CR5",
      "unstructured": "Wiethoff I, Goversen B, Michels M, van der Velden J, Hiligsmann M, Kugener T et al (2023) A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies. Neth Hear J 31:226–237. https://doi.org/10.1007/s12471-023-01776-1",
      "volume": "31",
      "year": "2023"
    },
    {
      "DOI": "10.1371/journal.pgph.0001795",
      "doi-asserted-by": "publisher",
      "key": "356_CR6",
      "unstructured": "Page C, Zheng H, Wang H, Singh Rai T, O’Kane M, Hart P et al (2023) A comparison of the Netherland, Norway and the UK Familial Hypercholesterolemia screening programmes with implications for target setting and the UK’s NHS Long Term Plan. PLOS Glob Public Heal 3. https://doi.org/10.1371/journal.pgph.0001795"
    },
    {
      "author": "Ontario Health (Quality)",
      "first-page": "1",
      "journal-title": "Ont Health Technol Assess Ser",
      "key": "356_CR7",
      "unstructured": "Ontario Health (Quality) (2022) Genetic testing for familial hypercholesterolemia: Health Technology Assessment. Ont Health Technol Assess Ser 22:1–155",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-023-01421-w",
      "author": "J Hayesmoore",
      "doi-asserted-by": "publisher",
      "first-page": "1003",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR8",
      "unstructured": "Hayesmoore J, Bhuiyan Z, Coviello D, du Sart D, Edwards M, Iascone M et al (2023) EMQN: recommendations for genetic testing in inherited cardiomyopathies and arrhythmias. Eur J Hum Genet 31:1003–1009. https://doi.org/10.1038/s41431-023-01421-w",
      "volume": "31",
      "year": "2023"
    },
    {
      "DOI": "10.1111/jce.16045",
      "author": "G Mascia",
      "doi-asserted-by": "publisher",
      "first-page": "2095",
      "journal-title": "J Cardiovasc Electrophysiol",
      "key": "356_CR9",
      "unstructured": "Mascia G, Brugada J, Arbelo E, Porto I (2023) Athletes and suspected catecholaminergic polymorphic ventricular tachycardia: awareness and current knowledge. J Cardiovasc Electrophysiol 34:2095–2101. https://doi.org/10.111/jce.16045",
      "volume": "34",
      "year": "2023"
    },
    {
      "key": "356_CR10",
      "unstructured": "Van Zelst-Stams W, Barge-Schaapveld D, Brilstra E, Christiaans I, van Dooren M, Douma K et al (2019) Richtlijn Informeren Van familieleden bij erfelijke aandoeningen. Ver Klin Genet Ned / Fed Med Spec"
    },
    {
      "DOI": "10.1093/eurheartj/ehad194",
      "author": "E Arbelo",
      "doi-asserted-by": "publisher",
      "first-page": "3503",
      "journal-title": "Eur Heart J",
      "key": "356_CR11",
      "unstructured": "Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C et al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 44:3503–3626. https://doi.org/10.1093/eurheartj/ehad194",
      "volume": "44",
      "year": "2023"
    },
    {
      "DOI": "10.1007/s10897-012-9544-4",
      "author": "EM Miller",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "J Genet Couns",
      "key": "356_CR12",
      "unstructured": "Miller EM, Wang Y, Ware SM (2013) Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families. J Genet Couns 22:258–267. https://doi.org/10.1007/s10897-012-9544-4",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ajmg.a.32710",
      "author": "I Christiaans",
      "doi-asserted-by": "publisher",
      "first-page": "602",
      "journal-title": "Am J Med Genet A",
      "key": "356_CR13",
      "unstructured": "Christiaans I, van Langen I, Birnie E, Bonsel G, Wilde A, Smets E (2009) Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 149A:602–612. https://doi.org/10.1002/ajmg.a.32710",
      "volume": "149A",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ejhg.2008.92",
      "author": "I Christiaans",
      "doi-asserted-by": "publisher",
      "first-page": "1201",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR14",
      "unstructured": "Christiaans I, Birnie E, Bonsel GJ, Wilde AAM, van Langen IM (2008) Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet 16:1201–1207. https://doi.org/10.1038/ejhg.2008.92",
      "volume": "16",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ajmg.a.32672",
      "author": "W Van der Roest",
      "doi-asserted-by": "publisher",
      "first-page": "357",
      "journal-title": "Am J Med Genet A",
      "key": "356_CR15",
      "unstructured": "Van der Roest W, Pennings J, Bakker M, van den Berg M, van Tintelen J (2009) Family letters are an effective way to inform relatives about inherited cardiac Disease. Am J Med Genet A 149A:357–363. https://doi.org/10.1002/ajmg.a.32672",
      "volume": "149A",
      "year": "2009"
    },
    {
      "DOI": "10.1002/ajmg.a.37455",
      "author": "C Burns",
      "doi-asserted-by": "publisher",
      "first-page": "418",
      "journal-title": "Am J Med Genet A",
      "key": "356_CR16",
      "unstructured": "Burns C, McGaughran J, Davis A, Semsarian C, Ingles J (2016) Factors influencing uptake of familial long QT syndrome genetic testing. Am J Med Genet A 170A:418–425. https://doi.org/10.1002/ajmg.a.37455",
      "volume": "170A",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.hrthm.2019.06.015",
      "author": "L Knight",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "Hear Rhythm",
      "key": "356_CR17",
      "unstructured": "Knight L, Miller E, Kovach J, Arscott P, von Alvensleben J, Bradley D et al (2020) Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy. Hear Rhythm 17:106–112. https://doi.org/10.1016/j.hrthm.2019.06.015",
      "volume": "17",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-021-00993-9",
      "author": "LM Van den Heuvel",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR18",
      "unstructured": "Van den Heuvel LM, Hoedemaekers YM, Baas AF, Baars MJH, van Tintelen JP, Smets EMA et al (2022) A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet 30:203–210. https://doi.org/10.1038/s41431-021-00993-9",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1161/CIRCGEN.119.002803",
      "author": "L Van den Heuvel",
      "doi-asserted-by": "publisher",
      "first-page": "524",
      "journal-title": "Circ Genom Precis Med",
      "key": "356_CR19",
      "unstructured": "Van den Heuvel L, van Teijlingen M, van der Roest W, van Langen I, Smets E, van Tintelen J et al (2020) Long-term Follow-Up study on the Uptake of Genetic Counseling and predictive DNA testing in inherited cardiac conditions. Circ Genom Precis Med 13:524–530. https://doi.org/10.1161/CIRCGEN.119.002803",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.gim.2022.100001",
      "author": "SY Park",
      "doi-asserted-by": "publisher",
      "first-page": "100001",
      "journal-title": "Genet Med",
      "key": "356_CR20",
      "unstructured": "Park SY, Kim Y, Kim S, Katapodi MC (2023) Informational needs of individuals from families harboring BRCA pathogenic variants: a systematic review and content analysis. Genet Med 25:100001. https://doi.org/10.1016/j.gim.2022.100001",
      "volume": "25",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41431-020-00725-5",
      "author": "S Srinivasan",
      "doi-asserted-by": "publisher",
      "first-page": "1631",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR21",
      "unstructured": "Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC (2020) Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet 28:1631–1644. https://doi.org/10.1038/s41431-020-00725-5",
      "volume": "28",
      "year": "2020"
    },
    {
      "key": "356_CR22",
      "unstructured": "Van den Heuvel L (2021) Informing relatives at risk of inherited (cardiac) conditions: On our way towards the best approach. Thesis, fully internal, Univ. van Amsterdam, p. 13–25"
    },
    {
      "DOI": "10.1002/jgc4.1604",
      "author": "A Cirino",
      "doi-asserted-by": "publisher",
      "first-page": "1290",
      "journal-title": "J Genet Couns",
      "key": "356_CR23",
      "unstructured": "Cirino A, Harris S, Murad A, Hansen B, Malinowski J, Natoli J et al (2022) The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis. J Genet Couns 31:1290–1305. https://doi.org/10.1002/jgc4.1604",
      "volume": "31",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.pecinn.2023.100138",
      "author": "M Ahsan",
      "doi-asserted-by": "publisher",
      "first-page": "100138",
      "journal-title": "PEC Innov",
      "key": "356_CR24",
      "unstructured": "Ahsan M, Levi S, Webster E, Bergeron H, Lin J, Narayan P et al (2023) Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis. PEC Innov 17:100138. https://doi.org/10.1016/j.pecinn.2023.100138",
      "volume": "17",
      "year": "2023"
    },
    {
      "DOI": "10.1038/ejhg.2015.122",
      "author": "J Hodgson",
      "doi-asserted-by": "publisher",
      "first-page": "356",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR25",
      "unstructured": "Hodgson J, Metcalfe S, Gaff C, Donath S, Delatycki M, Winship I et al (2016) Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication. Eur J Hum Genet 24:356–360. https://doi.org/10.1038/ejhg.2015.122",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41431-023-01400-1",
      "doi-asserted-by": "crossref",
      "key": "356_CR26",
      "unstructured": "Ballard LM, Band R, Lucassen A (2023) Interventions to support patients with sharing genetic test results with at-risk relatives: a synthesis without meta-analysis (SWiM). Eur J Hum Genet. ;31:988–1002. https://doi.org/0.1038/s41431-023-01400-1"
    },
    {
      "DOI": "10.1038/s41431-022-01200-z",
      "author": "A Young",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR27",
      "unstructured": "Young A, Imran A, Spoelma M, Williams R, Tucker K, Halliday J et al (2022) Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review. Eur J Hum Genet 31:18–34. https://doi.org/10.1038/s41431-022-01200-z",
      "volume": "31",
      "year": "2022"
    },
    {
      "DOI": "10.1097/GIM.0b013e318164540b",
      "author": "LE Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "journal-title": "Genet Med",
      "key": "356_CR28",
      "unstructured": "Forrest LE, Burke J, Bacic S, Amor DJ (2008) Increased genetic counseling support improves communication of genetic information in families. Genet Med 10:167–172. https://doi.org/10.1097/GIM.0b013e318164540b",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.22.00303",
      "author": "MK Frey",
      "doi-asserted-by": "publisher",
      "first-page": "4129",
      "journal-title": "J Clin Oncol",
      "key": "356_CR29",
      "unstructured": "Frey MK, Ahsan MD, Bergeron H, Lin J, Li X, Fowlkes RK et al (2022) Cascade Testing for Hereditary Cancer syndromes: should we move toward direct relative contact? A systematic review and Meta-analysis. J Clin Oncol 40:4129–4143. https://doi.org/10.1200/JCO.22.00303",
      "volume": "40",
      "year": "2022"
    },
    {
      "DOI": "10.1136/jmg.2007.051581",
      "author": "K Aktan-Collan",
      "doi-asserted-by": "publisher",
      "first-page": "732",
      "journal-title": "J Med Genet",
      "key": "356_CR30",
      "unstructured": "Aktan-Collan K, Haukkala A, Pylvänäinen K, Järvinen HJ, Aaltonen LA, Peltomäki P et al (2007) Direct contact in inviting high-risk members of hereditary colon Cancer families to genetic counselling and DNA testing. J Med Genet 44:732–738. https://doi.org/10.1136/jmg.2007.051581",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10689-015-9854-4",
      "author": "E Sermijn",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Fam Cancer",
      "key": "356_CR31",
      "unstructured": "Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E et al (2016) The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer 15:155–162. https://doi.org/10.1007/s10689-015-9854-4",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41436-019-0735-3",
      "author": "EM Bednar",
      "doi-asserted-by": "publisher",
      "first-page": "719",
      "journal-title": "Genet Med",
      "key": "356_CR32",
      "unstructured": "Bednar EM, Sun CC, McCurdy S, Vernon SW (2020) Assessing relatives’ readiness for hereditary cancer cascade genetic testing. Genet Med 22:719–726. https://doi.org/10.1038/s41436-019-0735-3",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s10689-015-9842-8",
      "author": "CHM Leenen",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "journal-title": "Fam Cancer",
      "key": "356_CR33",
      "unstructured": "Leenen CHM, den Heijer M, van der Meer C, Kuipers EJ, van Leerdam ME, Wagner A (2016) Genetic testing for Lynch syndrome: family communication and motivation. Fam Cancer 15:63–73. https://doi.org/10.1007/s10689-015-9842-8",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10897-014-9810-8",
      "author": "A Khouzam",
      "doi-asserted-by": "publisher",
      "first-page": "797",
      "journal-title": "J Genet Couns",
      "key": "356_CR34",
      "unstructured": "Khouzam A, Kwan A, Baxter S, Bernstein J (2015) Factors Associated with Uptake of Genetics Services for hypertrophic cardiomyopathy. J Genet Couns 24:797–809. https://doi.org/10.1007/s10897-014-9810-8",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10897-017-0164-x",
      "author": "S Dheensa",
      "doi-asserted-by": "publisher",
      "first-page": "689",
      "journal-title": "J Genet Couns",
      "key": "356_CR35",
      "unstructured": "Dheensa S, Lucassen A, Fenwick A (2018) Limitations and pitfalls of using Family letters to communicate genetic risk: a qualitative study with patients and Healthcare professionals. J Genet Couns 27:689–701. https://doi.org/10.1007/s10897-017-0164-x",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s12687-019-00418-7",
      "author": "C Zordan",
      "doi-asserted-by": "publisher",
      "first-page": "489",
      "journal-title": "J Community Genet",
      "key": "356_CR36",
      "unstructured": "Zordan C, Monteil L, Haquet E, Cordier C, Toussaint E, Al E (2019) Evaluation of the template letter regarding the disclosure of genetic information within the family in France. J Community Genet 10:489–499. https://doi.org/10.1007/s12687-019-00418-7",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.atherosclerosissup.2017.05.019",
      "author": "L Louter",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Atheroscler Suppl",
      "key": "356_CR37",
      "unstructured": "Louter L, Defesche J, van Roeters J (2017) Cascade screening for familial hypercholesterolemia: practical consequences. Atheroscler Suppl 30:77–85. https://doi.org/10.1016/j.atherosclerosissup.2017.05.019",
      "volume": "30",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03587-X",
      "author": "MAW Umans-Eckenhausen",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "journal-title": "Lancet",
      "key": "356_CR38",
      "unstructured": "Umans-Eckenhausen MAW, Defesche JC, Sijbrands EJG, Scheerder RLJM, Kastelein JJP (2001) Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357:165–168. https://doi.org/10.1016/S0140-6736(00)03587-X",
      "volume": "357",
      "year": "2001"
    },
    {
      "DOI": "10.1159/000064200",
      "author": "M Van Maarle",
      "doi-asserted-by": "publisher",
      "first-page": "244",
      "journal-title": "Community Genet",
      "key": "356_CR39",
      "unstructured": "Van Maarle M, Stouthard M, Marang-van de Mheen P, Klazinga N, Bonsel G (2001) How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees’ views. Community Genet 4:244–252. https://doi.org/10.1159/000064200",
      "volume": "4",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ajmg.a.10061",
      "author": "M Van Maarle",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "Am J Med Genet A",
      "key": "356_CR40",
      "unstructured": "Van Maarle M, Stouthard M, Bonsel G (2003) Risk perception of participants in a family-based genetic screening program on familial hypercholesterolemia. Am J Med Genet A 116A:136–143. https://doi.org/10.1002/ajmg.a.10061",
      "volume": "116A",
      "year": "2003"
    },
    {
      "author": "DM Kusters",
      "first-page": "D4675",
      "journal-title": "Ned Tijdschr Geneeskd",
      "key": "356_CR41",
      "unstructured": "Kusters DM, Hutten BA, Wiegman A, Cornel MC (2020) Opsporing en behandeling van erfelijk hoog cholesterol. Hoe eerder hoe beter? Ned Tijdschr Geneeskd 164:D4675",
      "volume": "164",
      "year": "2020"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201940",
      "author": "S Homsma",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR42",
      "unstructured": "Homsma S, Huijgen R, Middeldorp S, Sijbrands E, Kastelein J (2018) Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance. Eur J Hum Genet 16:14–17. https://doi.org/10.1038/sj.ejhg.5201940",
      "volume": "16",
      "year": "2018"
    },
    {
      "DOI": "10.1038/ejhg.2009.145",
      "author": "I Christiaans",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "journal-title": "Eur J Hum Genet",
      "key": "356_CR43",
      "unstructured": "Christiaans I, Kok T, van Langen I, Birnie E, Bonsel G, Wilde A et al (2010) Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers. Eur J Hum Genet 18:251–253. https://doi.org/10.1038/ejhg.2009.145",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jacl.2021.08.007",
      "author": "T Leren",
      "doi-asserted-by": "publisher",
      "first-page": "674",
      "journal-title": "Clin Lipidol",
      "key": "356_CR44",
      "unstructured": "Leren T, Bogsrud M (2021) The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: results from twenty years of a national screening program in Norway. Clin Lipidol 15:674–681. https://doi.org/10.1016/j.jacl.2021.08.007",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fgene.2022.867226",
      "doi-asserted-by": "publisher",
      "key": "356_CR45",
      "unstructured": "Schmidlen T, Bristow S, Hatchell K, Esplin E, Nussbaum R, Haverfield E (2022) The impact of Proband indication for genetic testing on the Uptake of Cascade Testing among relatives. Front Genet 867226. https://doi.org/10.3389/fgene.2022.867226"
    },
    {
      "DOI": "10.2196/32568",
      "author": "H Bangash",
      "doi-asserted-by": "publisher",
      "first-page": "e32568",
      "journal-title": "JMIR Hum",
      "key": "356_CR46",
      "unstructured": "Bangash H, Makkawy A, Gundelach J, Miller A, Jacobson K, Kullo I (2022) Web-based Tool (FH Family Share) to increase uptake of Cascade Testing for Familial Hypercholesterolemia: development and evaluation. JMIR Hum 9:e32568. https://doi.org/10.2196/32568",
      "volume": "9",
      "year": "2022"
    }
  ],
  "reference-count": 46,
  "references-count": 46,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-023-00356-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy"
}